Platelet Microvesicles
血小板微泡
基本信息
- 批准号:8195600
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-10-01 至 2013-09-30
- 项目状态:已结题
- 来源:
- 关键词:AgonistAntiphospholipid SyndromeBloodBlood CirculationBlood ClotBlood PlateletsBlood coagulationCoagulation ProcessCoenzymesComplexDeep Vein ThrombosisDiseaseDyesEndothelial CellsEquilibriumGenerationsGoalsHealthHemorrhageHemostatic functionHeparinHomologous GeneIn VitroIndividualInheritedLightMalignant NeoplasmsMammalian CellMediator of activation proteinMembraneModelingMorbidity - disease rateMusMyocardial InfarctionOpsoninPeripheralPhagocytosisPhosphatidylserinesPhospholipidsPlasmaPlayResearchRiskRoleScott syndromeStrokeSurfaceTestingThrombinThrombocytopeniaThrombosisThrombotic Thrombocytopenic PurpuraVenous ThrombosisVesicleVeteransabstractingartery occlusionatherothrombosiscell injuryin vivomacrophagemortality
项目摘要
Abstract
In platelets, phosphatidylserine (PS) is present exclusively in the inner leaflet of the membrane bilayer. Upon
activation with some agonists, platelets externalize PS and provide a procoagulant surface. Exposure of PS is
accompanied by the release of PS-rich procoagulant membrane fragments called platelet-derived
microvesicles. Deficiency of PS exposure and microvesiculation leads to an inherited bleeding disorder, Scott
syndrome. Increased microvesicles have been detected in conditions associated with either arterial or venous
thrombosis. These associations suggest that, while they may be necessary for normal hemostasis, elevated
microvesicles predispose to thrombosis. We have identified lactadherin and Del-1 (developmentally expressed
locus-1) as mediators of microvesicles clearance. Lactadherin and Del-1 are present in circulating
microvesicles and promotes their phagocytosis by macrophages in a concentration-dependent manner in vitro.
Lactadherin-deficient mice have increased microvesicles in the circulation and an enhanced thrombin
generation in their plasma. Furthermore, in a light-dye-induced endothelial cell injury/thrombosis model,
lactadherin-deficient mice have increased thrombotic tendency compared to wild type littermate controls. Our
goals in the current proposal are to define the mechanism(s) of microvesicles clearance and its relation to
thrombosis. We will also test the hypothesis that impaired clearance of the microvesicles per s¿ leads to a
hypercoagulable state in antiphospholipid antibody syndrome. The specific aims of this proposal are to further
characterize the role of lactadherin and Del-1 in the clearance of microvesicles in vivo and to test the
hypothesis that microvesicles causes thrombosis in antiphospholipid syndrome.
摘要
在血小板中,磷脂酰丝氨酸(PS)仅存在于膜双层的内小叶中。后
在某些激动剂的激活下,血小板使PS外化并提供促凝血表面。PS的暴露是
伴随着富含PS的促凝血膜片段的释放,称为血小板衍生的
微泡缺乏PS暴露和微泡形成导致遗传性出血性疾病,斯科特
综合征在与动脉或静脉相关的疾病中检测到微泡增加
血栓形成这些相关性表明,虽然它们可能是正常止血所必需的,但升高的
微囊泡易于血栓形成。我们已经鉴定了乳凝集素和Del-1(发育表达
locus-1)作为微泡清除的介质。Lactadherin和Del-1存在于循环中,
在体外以浓度依赖性的方式促进微囊泡被巨噬细胞吞噬。
Lactadherin缺陷小鼠循环中的微泡增加,凝血酶增强
在他们的血浆中。此外,在光染料诱导的内皮细胞损伤/血栓形成模型中,
与野生型同窝对照相比,乳凝集素缺陷小鼠具有增加的血栓形成倾向。我们
当前提案的目标是定义微泡清除的机制及其与
血栓形成我们还将检验以下假设,即微囊泡的清除率受损会导致
抗磷脂抗体综合征高凝状态这项建议的具体目的是进一步
表征乳粘附素和Del-1在体内微泡清除中的作用,并测试
微泡导致抗磷脂综合征血栓形成的假说。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Perumal Thiagarajan其他文献
Perumal Thiagarajan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Perumal Thiagarajan', 18)}}的其他基金
相似海外基金
Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome
抗磷脂综合征中 Beta-2 糖蛋白 I 的结构研究
- 批准号:
10320750 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome
抗磷脂综合征中 Beta-2 糖蛋白 I 的结构研究
- 批准号:
10561597 - 财政年份:2019
- 资助金额:
-- - 项目类别:
A prospective study evaluating complement activation among pregnant patients with obstetrical antiphospholipid syndrome
一项评估产科抗磷脂综合征妊娠患者补体激活的前瞻性研究
- 批准号:
405079 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Operating Grants
Molecular Basis of Pregnancy Complications in the Antiphospholipid Syndrome
抗磷脂综合征妊娠并发症的分子基础
- 批准号:
9764402 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Preparation of diagnostic guidelines for antiphospholipid syndrome and elucidation of the mechanism for arterial and venous thrombosis.
制定抗磷脂综合征诊断指南并阐明动静脉血栓形成机制。
- 批准号:
18K07468 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Synergistic effects of antiphospholipid antibodies and oxidative stress that increase the risk of thrombosis in antiphospholipid syndrome
抗磷脂抗体和氧化应激的协同作用会增加抗磷脂综合征中血栓形成的风险
- 批准号:
18K16117 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular Basis of Pregnancy Complications in the Antiphospholipid Syndrome
抗磷脂综合征妊娠并发症的分子基础
- 批准号:
10183277 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Molecular Basis of Pregnancy Complications in the Antiphospholipid Syndrome
抗磷脂综合征妊娠并发症的分子基础
- 批准号:
10411934 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Molecular Basis of Pregnancy Complications in the Antiphospholipid Syndrome
抗磷脂综合征妊娠并发症的分子基础
- 批准号:
9922707 - 财政年份:2018
- 资助金额:
-- - 项目类别:
MICA: Development of PEGylated Domain I of beta-2-glycoprotein I as a new therapeutic agent for the antiphospholipid syndrome
MICA:开发 β-2-糖蛋白 I 的聚乙二醇化结构域 I 作为抗磷脂综合征的新治疗剂
- 批准号:
MR/P017371/1 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Research Grant